aquisição urgente medicamentos

ID 12020491 · Portal BASE
Price
Base Price
€67,724 .00
Effective Price
€67,724 .00 0.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33000000
Location
Portugal, Setúbal, Setúbal
Bidder Count
—
Winners
LABESFAL - LABORATÓRIOS ALMIRO S.A.
NIF 501169580
Company
TEVA PHARMA - PRODUTOS FARMACÊUTICOS LDA
NIF 507045491
Company
ABBOTT MEDICAL OPTICS SPAIN, S.L. SUCURSAL EM PORTUGAL
NIF 980262364
Company
ZAMBON-PRODUTOS FARMACEUTICOS
NIF 502155930
Company
SANDOZ FARMACÊUTICA LDA
NIF 506985261
Company
PHARMIS BIOFARMACÊUTICA LDA
NIF 502595442
Company
Roche Farmacêutica Química, Lda.
NIF 500233870
Company
NOVARTIS FARMA - PRODUTOS FARMACÊUTICOS S.A.
NIF 500063524
Company
VIFOR PHARMA PORTUGAL, SA
NIF 516677586
Company
BIOJAM SA
NIF 513642749
Company
NORGINE PORTUGAL FARMACEUTICA UNIPESSOAL , LDA
NIF 508676746
Company
GILEAD SCIENCES LDA
NIF 503604704
Company
DLA FARMACEUTICA SA
NIF 503894427
Company
AMGEN-BIO-FARMACÊUTICA LDA
NIF 502942959
Company
FRESENIUS KABI PHARMA PORTUGAL LDA
NIF 504293753
Company
LABORATÓRIOS PFIZER LDA
NIF 500162166
Company
UCB Lda.
NIF 500291322
Company
CLINIFAR - PRODUTOS CLÍNICOS E FARMACEUTICOS S.A.
NIF 503281115
Company
JABA RECORDATI, SA.
NIF 500492867
Company
Nestlé Portugal, S.A.
NIF 500201307
Company
OCTAPHARMA-PRODUTOS FARMACÊUTICOS LDA
NIF 502820780
Company
Dates
Publication
05 Dec 2025
Celebration
01 Jul 2025
Contracting Entity
Centro Hospitalar de Setúbal, EPE
NIF 507606787
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 90 · HIGH RISK
A1 · Repeat Direct Award
A1_REPEAT_DIRECT_AWARD
HIGH
Authority
20
Supplier
424
Number of Awards
9
Rule
A1 repeat direct award: 9 awards within 36 months
Detected 2026-03-06
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
05 Dec 2025
Signing Date
01 Jul 2025
Days Late
157
Rule
A2/A3 late publication: 157 days after signing (threshold: 10)
Detected 2026-03-06